Biotech Values

[dewophile]

Cvac thinks their tech enables lower doses than MRNA and even PFE in vaccines. This could translate to an advantage if you need a multivalent covid vaccine down the road to hit multiple mutants
I don’t think GSK is contributing any technology (unlike some other deals where they chip in their adjuvant )